全文获取类型
收费全文 | 561篇 |
免费 | 49篇 |
国内免费 | 1篇 |
出版年
2023年 | 7篇 |
2021年 | 23篇 |
2020年 | 20篇 |
2019年 | 13篇 |
2018年 | 14篇 |
2017年 | 14篇 |
2016年 | 25篇 |
2015年 | 37篇 |
2014年 | 47篇 |
2013年 | 39篇 |
2012年 | 48篇 |
2011年 | 52篇 |
2010年 | 27篇 |
2009年 | 20篇 |
2008年 | 32篇 |
2007年 | 36篇 |
2006年 | 32篇 |
2005年 | 30篇 |
2004年 | 24篇 |
2003年 | 24篇 |
2002年 | 19篇 |
2001年 | 4篇 |
2000年 | 7篇 |
1999年 | 1篇 |
1998年 | 4篇 |
1997年 | 3篇 |
1996年 | 2篇 |
1995年 | 4篇 |
1994年 | 2篇 |
1990年 | 1篇 |
排序方式: 共有611条查询结果,搜索用时 46 毫秒
1.
Cathrine Laustrup M?ller Rasmus Kj?bsted Pablo J. Enriori Thomas Elbenhardt Jensen Cecilia Garcia-Rudaz Sara A. Litwak Kirsten Raun J?rgen Wojtaszewski Birgitte Schjellerup Wulff Michael A. Cowley 《PloS one》2016,11(7)
The melanocortin system includes five G-protein coupled receptors (family A) defined as MC1R-MC5R, which are stimulated by endogenous agonists derived from proopiomelanocortin (POMC). The melanocortin system has been intensely studied for its central actions in body weight and energy expenditure regulation, which are mainly mediated by MC4R. The pituitary gland is the source of various POMC-derived hormones released to the circulation, which raises the possibility that there may be actions of the melanocortins on peripheral energy homeostasis. In this study, we examined the molecular signaling pathway involved in α-MSH-stimulated glucose uptake in differentiated L6 myotubes and mouse muscle explants. In order to examine the involvement of AMPK, we investigate α-MSH stimulation in both wild type and AMPK deficient mice. We found that α-MSH significantly induces phosphorylation of TBC1 domain (TBC1D) family member 1 (S237 and T596), which is independent of upstream PKA and AMPK. We find no evidence to support that α-MSH-stimulated glucose uptake involves TBC1D4 phosphorylation (T642 and S704) or GLUT4 translocation. 相似文献
2.
3.
4.
Genomic Resources Development Consortium Mariella Baratti Federica Cattonaro Tiziana Di Lorenzo Diana Maria Paola Galassi Valentina Iannilli Alessio Iannucci Just Jensen Peter Foged Larsen Rasmus O. Nielsen Cino Pertoldi Dragos Postolache Jose Martin Pujolar Ettore Randi Aritz Ruiz‐Gonzalez Janne Pia Thirstrup Giovanni Giuseppe Vendramin Andrzej Zalewski 《Molecular ecology resources》2015,15(2):458-459
5.
6.
A hallmark of the gluten-driven enteropathy celiac disease is autoantibody production towards the enzyme transglutaminase 2 (TG2) that catalyzes the formation of covalent protein-protein cross-links. Activation of TG2-specific B cells likely involves gluten-specific CD4 T cells as production of the antibodies is dependent on disease-associated HLA-DQ allotypes and dietary intake of gluten. IgA plasma cells producing TG2 antibodies with few mutations are abundant in the celiac gut lesion. These plasma cells and serum antibodies to TG2 drop rapidly after initiation of a gluten-free diet, suggestive of extrafollicular responses or germinal center reactions of short duration. High antigen avidity is known to promote such responses, and is also important for breakage of self-tolerance. We here inquired whether TG2 avidity could be a feature relevant to celiac disease. Using recombinant enzyme we show by dynamic light scattering and gel electrophoresis that TG2 efficiently utilizes itself as a substrate due to conformation-dependent homotypic association, which involves the C-terminal domains of the enzyme. This leads to the formation of covalently linked TG2 multimers. The presence of exogenous substrate such as gluten peptide does not inhibit TG2 self-cross-linking, but rather results in formation of TG2-TG2-gluten complexes. The celiac disease autoantibody epitopes, clustered in the N-terminal part of TG2, are conserved in the TG2-multimers as determined by mass spectrometry and immunoprecipitation analysis. TG2 multimers are superior to TG2 monomer in activating A20 B cells transduced with TG2-specific B-cell receptor, and uptake of TG2-TG2-gluten multimers leads to efficient activation of gluten-specific T cells. Efficient catalytic self-multimerization of TG2 and generation of multivalent TG2 antigen decorated with gluten peptides suggest a mechanism by which self-reactive B cells are activated to give abundant numbers of plasma cells in celiac disease. Importantly, high avidity of the antigen could explain why TG2-specific plasma cells show signs of an extrafollicular generation pathway. 相似文献
7.
8.
Xi Chen Kathrin Hnida Melissa Ann Graewert Jan Terje Andersen Rasmus Iversen Anne Tuukkanen Dmitri Svergun Ludvig M. Sollid 《The Journal of biological chemistry》2015,290(35):21365-21375
Antibodies to the autoantigen transglutaminase 2 (TG2) are a hallmark of celiac disease. We have studied the interaction between TG2 and an anti-TG2 antibody (679-14-E06) derived from a single gut IgA plasma cell of a celiac disease patient. The antibody recognizes one of four identified epitopes targeted by antibodies of plasma cells of the disease lesion. The binding interface was identified by small angle x-ray scattering, ab initio and rigid body modeling using the known crystal structure of TG2 and the crystal structure of the antibody Fab fragment, which was solved at 2.4 Å resolution. The result was confirmed by testing binding of the antibody to TG2 mutants by ELISA and surface plasmon resonance. TG2 residues Arg-116 and His-134 were identified to be critical for binding of 679-14-E06 as well as other epitope 1 antibodies. In contrast, antibodies directed toward the two other main epitopes (epitopes 2 and 3) were not affected by these mutations. Molecular dynamics simulations suggest interactions of 679-14-E06 with the N-terminal domain of TG2 via the CDR2 and CDR3 loops of the heavy chain and the CDR2 loop of the light chain. In addition there were contacts of the framework 3 region of the heavy chain with the catalytic domain of TG2. The results provide an explanation for the biased usage of certain heavy and light chain gene segments by epitope 1-specific antibodies in celiac disease. 相似文献
9.
Nicklas H Staunstrup Nynne Sharma Rasmus O Bak Lars Svensson Thomas K Petersen Lene Aarenstrup Karsten Kristiansen Lars Bolund Jacob Giehm Mikkelsen 《BMC biotechnology》2011,11(1):33
Background
Analogues of vitamin D3 are extensively used in the treatment of various illnesses, such as osteoporosis, inflammatory skin diseases, and cancer. Functional testing of new vitamin D3 analogues and formulations for improved systemic and topical administration is supported by sensitive screening methods that allow a comparative evaluation of drug properties. As a new tool in functional screening of vitamin D3 analogues, we describe a genomically integratable sensor for sensitive drug detection. This system facilitates assessment of the pharmacokinetic and pharmadynamic properties of vitamin D3 analogues. The tri-cistronic genetic sensor encodes a drug-sensoring protein, a reporter protein expressed from an activated sensor-responsive promoter, and a resistance marker. 相似文献10.
Lie Maria E. K. Kickinger Stefanie Skovgaard-Petersen Jonas Ecker Gerhard F. Clausen Rasmus P. Schousboe Arne White H. Steve Wellendorph Petrine 《Neurochemical research》2020,45(7):1551-1565
Neurochemical Research - Focal epileptic seizures can in some patients be managed by inhibiting γ-aminobutyric acid (GABA) uptake via the GABA transporter 1 (GAT1) using tiagabine... 相似文献